Article
Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.
Haematologica - 1 Feb 2014
Kaneko Kiriko, Furuyama Kazumichi, Fujiwara Tohru, Kobayashi Ryoji, Ishida Hiroyuki, Harigae Hideo, Shibahara Shigeki
Abstract excerpt
Erythroid-specific 5-aminolevulinate synthase (ALAS2) is the rate-limiting enzyme for heme biosynthesis in erythroid cells, and a missense mutation of the ALAS2 gene is associated with congenital sideroblastic anemia. However, the gene responsible for this form of anemia remains unclear in about 40% of patients. Here, we identify a novel erythroid-specific enhancer of 130 base pairs in the first intron of the...
Topics
- 5-Aminolevulinate Synthetase
- Anemia, Sideroblastic
- Enhancer Elements, Genetic
- GATA1 Transcription Factor
- Humans
- K562 Cells
- Male
- Mutation
- Response Elements
